Evidence map›Paper›PMID 33477899›Full record

ArticleInternational journal of molecular sciences2021

Extracellular Prolidase (PEPD) Induces Anabolic Processes through EGFR, β

Weronika Baszanowska, Magdalena Misiura, Ilona Oscilowska, Jerzy Palka, Wojciech Miltyk

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Molecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. International journal of molecular sciences · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Weronika BaszanowskaDepartment of Medicinal Chemistry, Medical University of Bialystok, Kilińskiego 1, 15-089 Bialystok, Poland.
Magdalena MisiuraDepartment of Analysis and Bioanalysis of Medicines, Medical University of Bialystok, Kilińskiego 1, 15-089 Bialystok, Poland.ORCID 0000-0002-8641-2991
Ilona OscilowskaDepartment of Medicinal Chemistry, Medical University of Bialystok, Kilińskiego 1, 15-089 Bialystok, Poland.ORCID 0000-0002-7934-6973
Jerzy PalkaDepartment of Medicinal Chemistry, Medical University of Bialystok, Kilińskiego 1, 15-089 Bialystok, Poland.ORCID 0000-0002-8476-2023
Wojciech MiltykDepartment of Analysis and Bioanalysis of Medicines, Medical University of Bialystok, Kilińskiego 1, 15-089 Bialystok, Poland.ORCID 0000-0001-5150-6093
Medical University of Białystok · PL

Funding

European Union funds, Operational Programme Knowledge Education Development for the years 2014-2020 POWR.03.02.00-00-I051/16Narodowe Centrum Nauki 2017/25/B/NZ7/02650
6 · The paper itself

Abstract

The role of prolidase (PEPD) as a ligand of the epidermal growth factor receptor (EGFR) was studied in an experimental model of wound healing in cultured fibroblasts. The cells were treated with PEPD (1-100 nM) and analysis of cell viability, proliferation, migration, collagen biosynthesis, PEPD activity, and the expressions of EGFR, insulin-like growth factor 1 (IGF-1), and β

Indexed as

AnimalsDipeptidasesErbB ReceptorsFibroblastsGene Expression RegulationHumansIntegrin beta1MiceReceptor, IGF Type 1Signal TransductionSkinWound HealingDipeptidasesEGFR protein, humanErbB ReceptorsIGF1R protein, humanIntegrin beta1proline dipeptidaseReceptor, IGF Type 1EGFRfibroblastsIGF-1PEPDprolidasewound healingβ1-integrin

Identifiers

PMID33477899
PMCPMC7833428
OpenAlexW3121765544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.